Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oral Cavity Carcinoma
|
16 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Squamous cell carcinoma
|
257 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Bladder Neoplasm
|
281 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.020 | 1.000 | 2 | 2011 | 2013 | ||||
Carcinoma of bladder
|
309 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.020 | 1.000 | 2 | 2011 | 2013 | ||||
Head and Neck Carcinoma
|
118 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.020 | 2 | 2008 | 2013 | |||||
Malignant Head and Neck Neoplasm
|
118 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.020 | 2 | 2008 | 2013 | |||||
Malignant neoplasm of urinary bladder
|
316 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.020 | 1.000 | 2 | 2011 | 2013 | ||||
Acute respiratory failure
|
5 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Brain Neoplasms
|
204 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Hyperhomocysteinemia
|
45 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Pleurisy
|
7 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Gallbladder Carcinoma
|
75 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.040 | 0.500 | 4 | 2007 | 2014 | ||||
Non-Small Cell Lung Carcinoma
|
712 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.040 | 1.000 | 4 | 2005 | 2014 | ||||
Malignant neoplasm of gallbladder
|
81 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.667 | 3 | 2007 | 2014 | ||||
Polycystic Ovary Syndrome
|
363 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.333 | 3 | 2009 | 2014 | ||||
Stage 0 Gallbladder Cancer AJCC v8
|
56 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.667 | 3 | 2007 | 2014 | ||||
Stage IIA Gallbladder Cancer AJCC v8
|
56 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.667 | 3 | 2007 | 2014 | ||||
Stage IIB Gallbladder Cancer AJCC v8
|
56 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.667 | 3 | 2007 | 2014 | ||||
Stage III Gallbladder Cancer AJCC v8
|
56 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.667 | 3 | 2007 | 2014 | ||||
Stage IV Gallbladder Cancer AJCC v8
|
56 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.667 | 3 | 2007 | 2014 | ||||
Male infertility
|
146 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Lip and Oral Cavity Carcinoma
|
172 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.333 | 3 | 2012 | 2015 | ||||
Malignant neoplasm of mouth
|
184 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.333 | 3 | 2012 | 2015 | ||||
Bone neoplasms
|
4 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.010 | 1 | 2015 | 2015 |